121 related articles for article (PubMed ID: 32014148)
1. Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-HER2 Treatments.
Kirova YM; Loap P; Fourquet A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):511-513. PubMed ID: 32014148
[No Abstract] [Full Text] [Related]
2. The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy.
Lanning RM; Morrow M; Riaz N; McArthur HL; Dang C; Moo TA; El-Tamer M; Krause K; Siu C; Hsu M; Zhang Z; Pei X; McCormick B; Powell SN; Ho A
Ann Surg Oncol; 2015 Aug; 22(8):2517-25. PubMed ID: 25564167
[TBL] [Abstract][Full Text] [Related]
3. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.
Weiss A; Lin H; Babiera GV; Bedrosian I; Shaitelman SF; Shen Y; Kuerer HM; Mittendorf EA; Caudle AS; Hunt KK; Hwang RF
Breast Cancer Res Treat; 2019 Jul; 176(2):435-444. PubMed ID: 31025270
[TBL] [Abstract][Full Text] [Related]
4. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women.
Fowble B; Jairam AK; Wang F; Peled A; Alvarado M; Ewing C; Esserman L; Park C; Lazar A
Clin Breast Cancer; 2018 Feb; 18(1):e107-e113. PubMed ID: 28830795
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.
Hehr T; Baumann R; Budach W; Duma MN; Dunst J; Feyer P; Fietkau R; Haase W; Harms W; Krug D; Piroth MD; Sedlmayer F; Souchon R; Wenz F; Sauer R;
Strahlenther Onkol; 2019 Nov; 195(11):949-963. PubMed ID: 31451835
[TBL] [Abstract][Full Text] [Related]
6. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
Wu SP; Tam M; Shaikh F; Lee A; Chun J; Schnabel F; Guth A; Adams S; Schreiber D; Oh C; Gerber NK
Ann Surg Oncol; 2018 Sep; 25(9):2620-2631. PubMed ID: 29987606
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).
Houvenaeghel G; Lambaudie E; Cohen M; Classe JM; Reyal F; Garbay JR; Giard S; Chopin N; Martinez A; Rouzier R; Daraï E; Colombo PE; Coutant C; Gimbergues P; Azuar P; Villet R; Tunon de Lara C; Barranger E; Sabiani L; Goncalves A
Breast; 2017 Aug; 34():24-33. PubMed ID: 28475932
[TBL] [Abstract][Full Text] [Related]
8. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy.
Wu SG; He ZY; Li Q; Li FY; Lin Q; Lin HX; Guan XX
Breast; 2012 Oct; 21(5):657-61. PubMed ID: 22835918
[TBL] [Abstract][Full Text] [Related]
10. Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.
Wright JL; Takita C; Reis IM; Zhao W; Saigal K; Wolfson A; Markoe A; Moller M; Hurley J
Cancer; 2013 Jan; 119(1):16-25. PubMed ID: 22736498
[TBL] [Abstract][Full Text] [Related]
11. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.
Tseng YD; Uno H; Hughes ME; Niland JC; Wong YN; Theriault R; Blitzblau RC; Moy B; Breslin T; Edge SB; Hassett MJ; Punglia RS
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):622-30. PubMed ID: 26461004
[TBL] [Abstract][Full Text] [Related]
12. Post-mastectomy radiation therapy in breast cancer patients with 1-3 positive lymph nodes: No one size fits all.
Kayali M; Abi Jaoude J; Tfayli A; El Saghir N; Poortmans P; Zeidan YH
Crit Rev Oncol Hematol; 2020 Mar; 147():102880. PubMed ID: 32045847
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
14. Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.
Shi Z; Peddi P; Burton G; Mills G; Shi R
Anticancer Res; 2016 Jan; 36(1):261-9. PubMed ID: 26722052
[TBL] [Abstract][Full Text] [Related]
15. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
16. Post-mastectomy radiation therapy in breast cancer with 1-3 involved lymph nodes: the Pros.
Tada K; Nishioka K; Kikuchi Y; Niwa T; Seto Y
Breast Cancer; 2017 Jul; 24(4):502-504. PubMed ID: 28585002
[TBL] [Abstract][Full Text] [Related]
17. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Breast Cancer Adjuvant Radiation and Integration of Breast and Reconstructive Surgery.
Kuerer HM; Cordeiro PG; Mutter RW
Am Soc Clin Oncol Educ Book; 2017; 37():93-105. PubMed ID: 28561684
[TBL] [Abstract][Full Text] [Related]
19. Post-mastectomy Radiation: Should Subtype Factor into the Decision?
Scheer AS; Zih FS; Maki E; Koch CA; McCready DR
Ann Surg Oncol; 2016 Aug; 23(8):2462-70. PubMed ID: 27008587
[TBL] [Abstract][Full Text] [Related]
20. Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.
He ZY; Wu SG; Zhou J; Li FY; Lin Q; Lin HX; Sun JY
PLoS One; 2015; 10(3):e0119105. PubMed ID: 25781605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
